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Streptolysin S, a streptococcal toxin of current 
interest, consists of a polypeptide attached to a poly¬ 
ribonucleotide (40)(4l). The active component of the 
complex appears to be polypeptide, and the polyribonu¬ 
cleotide functions as a carrier (20). 
Possible Role of Streptolysin S in the Pathogene¬ 
sis of Rheumatic Fever: Rheumatic fever is a non¬ 
suppurative sequel of streptococcal infections, but its 
pathogenesis remains obscure. Auto-antibodies to heart 
tissue have been demonstrated in this disease (38)(28), 
but whether they play a pathogenetic role remains 
questionable. Most auto-antibodies in other clinical 
and experimental conditions appear to be innocuous and 
some may even be protective (46)(76). 
The natural history of rheumatic fever, with its 
multiple recurrences without shortening of the latent 
period, (51) is unlike the experimental models of aller¬ 
gic diseases and could well be explained by a non- 
antigenic toxin of group A streptococci. Such is the 
oxygen-stable streptococcal hemolysin, or streptolysin 
S. A potent hemolytic and lysosome-disrupting agent 
(82), this toxin has some added features which further 
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Increase its likelihood of being the agent of damage 
in rheumatic fever: (I) it can be produced by non¬ 
dividing cells (1), such as one would expect to find 
in the convalescent stage of streptococcal infections, ■ 
during the latent period of rheumatic fever; and (II) 
its inhibitor, normally present in the serum of man 
and other animals, is decreased in patients with active 
rheumatic fever (60)(79). Another intriguing obser¬ 
vation is the mitosis-stimulating effect of streptoly¬ 
sin S on the peripheral lymphocytes of normal subjects 
and of patients with diseases other than rheumatic 
fever, but not of patients with rheumatic fever (30). 
It Is therefore believed that this study on the immuno- 
genicity of streptolysin S may provide information 
relevant to the pathogenesis of rheumatic fever. If a 
means were found to immunize experimental animals against 
streptolysin S, it would be of interest to adapt such 
means to man, and test the hypothesis that immunization 
may prevent rheumatic fever. 
At the outset It is important to note that strep¬ 
tolysin S is presently considered to be non-antigenic. 
More specifically, one may state that heretofore strep¬ 
tolysin S (as It is prepared In the laboratory) has been 
shown to be non-antigenic under certain well-defined 
conditions (to be discussed in the next subdivision). 
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However, a categorical statement cannot justifiably be 
made as to the antigenicity of streptolysin S because 
many alternative methods of demonstrating its anti¬ 
genicity or lack of antigenicity remain to be explored. 
The possibility of making streptolysin S antigenic 
by utilizing it as a hapten and coupling it to a protein 
moiety which would serve as a carrier has not been tested. 
Such an approach will be used in the present study. 
Antigenicity of Streptococcal Hemolysins: The study 
of streptococcal hemolysins was greatly clarified by Todd 
(78), who first clearly differentiated streptolysin S, a 
serum-soluble, oxygen-stable hemolysin, from streptolysin 
0, which is readily formed in serum-free media and is 
inactivated by oxygen. It has been shown by him (77), 
and by many workers since, that streptolysin 0 is a 
powerful antigen, and that infection with strains of 
streptococcus which produce this hemolysin is generally 
followed by a sharp rise in the antistreptolysin 0 con¬ 
tent of the serum. 
In 1939, Todd, Cobum, and Hill published a study of 
antistreptolysin S and 0 titers in normal adults, non¬ 
rheumatic children with, or recovering from, hemolytic 
streptococcal infections, rheumatic children suffering 
from similar infections, but with no rheumatic activity, 
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and rheumatic children in whom streptococcal infection 
was followed by an acute attach of rheumatic fever. The 
variations in the antistreptolysin S titer were not 
large. However, from a statistical analysis of their 
data, these authors concluded that in response to in¬ 
fection with hemolytic streptococci there is a rise in 
the antistreptolysin S titer considerably above the nor¬ 
mal level in the sera of all groups studied. Those 
rheumatic children who developed clinical signs of 
rheumatic activity were the only exception^ In the sera 
of these children the antistreptolysin S titer, although 
often above normal, tended to remain relatively low. 
Sera taken during the period of acute rheumatic fever 
showed lower antistreptolysin S titers than sera taken 
from the same patients during periods of rheumatic in¬ 
activity. Furthermore, during rheumatic attacks the 
antistreptolysin S titers tended to be lowest when the 
clinical symptoms were most pronounced. Todd e_fc al. 
regarded the antistreptolysin S titer of human sera as 
due to a specific antibody. The fall in titer which 
occurred during rheumatic activity they considered as 
evidence of an abnormal antibody response (79). 
Humphrey (33) conducted a study on sera taken from 
patients with streptococcal infections, rheumatic fever, 
and rheumatoid arthritis in various stages of their disease 
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as well as in normal controls. Nearly all sera taken 
from sick persons had lower antistreptolysin S titers 
than those from normal controls. The highest anti¬ 
streptolysin S titers were found in normal adults and 
in late convalescent cases of rheumatic fever. In the 
acute phases of streptococcal infections, rheumatic 
fever, and rheumatoid arthritis and during the early 
stages of convalescence, the antistreptolysin S titers 
were comparatively low. 
Stollerman and 3emheimerfs study in 1950 (60) 
confirmed the phenomenon of decreased antistreptolysin 
S titers in the sera of patients with clinically active 
acute rheumatic fever first noted by Todd e_t al. (79). 
It was also apparent that the fall in titer was not a 
decrease in antibody, but more likely reflected a meta¬ 
bolic disturbance which resulted in a diminution of a 
normal component of serum. That the fall in antistrep¬ 
tolysin S is not specific for rheumatic fever was demon¬ 
strated by the finding of low titers in some cases of 
diseases unrelated to streptococcal infection (60). The 
failure of any patient in this study to show'a rise in 
the serum titer against streptolysin 3 following proved 
streptococcal infection, or during the course of rheumatic 
fever, when streptococcal antibodies had been demonstrated 
at very high levels, is evidence that streptolysin 
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S is not antigenic in natural streptococcal infections 
in man. On the basis of these facts, in conjunction 
with the constancy and narrow range of antistreptolysin 
S titer in normal human sera, Stollerman and Bernheimer 
suggested that the inhibition of streptolysin S by human 
serum is due to a normal component of serum rather than 
to a specific antibody. They also suggested that the 
term "antistreptolysin S" be abandoned since this denotes 
an antibody, and they substituted the noncommittal expres¬ 
sion "streptolysin S inhibitor" (SSI). 
Todd reported that streptolysin 3 is not antigenic 
when injected by itself. Pour rabbits were injected sub¬ 
cutaneously and intravenously with approximately 36,000 
50$ hemolytic units of streptolysin S in 16 doses, without 
eliciting an antistreptolysin S rise. He, however, ini¬ 
tially claimed that by prolonged courses of intravenous 
injections of living group A streptococci into rabbits 
it was possible to obtain antisera to streptolysin S. 
(One rabbit developed an antistreptolysin S titer of 400 
one week after a repeat I.V. injection with living strep¬ 
tococci; other rabbits similarly treated developed no 
rises or smaller rises—to less than 100 units. About 
half the rabbits died during the course of the immuni¬ 




Humphrey (33) repeated these Immunization efforts 
by giving rabbits intravenous injections of streptococci. 
The first two injections consisted of hilled organisms, 
but all later injections were of living streptococci. 
Injections were given two or three times weekly, with 
rest periods of 20 days or more in between courses. The 
total volume of packed living organisms injected varied 
from 0.6 to 1.0 ml., and of culture fluid from 12 to 20 
ml. A horse was also injected with five intramuscular 
doses of formolized culture filtrate from streptococci 
grown in yeast nucleic acid broth. These five injections 
were followed by a total of nearly three liters of untreat¬ 
ed filtrate, in 26 doses over a period of 15 weeks. No 
evidence was obtained of an increase in antistreptolysin 
S titer in either the rabbits or the horse. 
Stolleraan, Bemheimer, and McLeod (61) injected one 
group of rabbits with one mgm. of streptolysin S subcu¬ 
taneously twice weekly for two weeks followed by a rest 
period of two weeks. Twelve injections were given over a 
period of three months. A second group of rabbits was 
injected intravenously twice weekly with 0.8 mgm. of 
streptolysin S per kg. of body weight at each injection. 
A total of nine injections was given. A third group of 
rabbits was injected twice weekly according to the schedule 
outlined by Toad (78), with increasing doses of whole 
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culture of living hemolytic streptococci grown in neopep¬ 
tone meat infusion broth, for 18 hours at 37°C. Specific 
antibodies to streptolysin S did not appear and no in¬ 
crease in inhibitory action was observed in these rabbits. 
In 1965 Taranta and Bernheimer attempted immunization 
of guinea pigs against streptolysin S toxoid (74). The 
reason for using streptolysin S in a toxoid form was to 
be able to give a very large dose of the toxin without 
killing the experimental animal. In this experiment a 
-total of 50 mgm. of streptolysin S was injected into each 
of two guinea pigs with complete Freund * s adjuvant (20 
mgm./ml., 10,000 units/mgm.), corresponding to 500,000 
hemolytic units before formolization and to 5,000 units 
after formolization. ho neutralizing antibody response 
was detected. Ouchterlony plates with the same strepto¬ 
lysin S preparation were negative for precipitating anti¬ 
bodies. 
Thus, all of the attempts described above to immunize 
animals against streptolysin S were unsuccessful. 
Toxicity of Streptolysin S: Weld (83), (84), Hare 
(26), and Barnard and Todd (2) studied the toxic effect 
of serum-extracted hemolysin (serum filtrates of living 
streptococci possessing hemolytic activity) in the mouse. 
Toxic manifestations depended on the amount of hemolysin 
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injected. Following the injection of streptococcal ex¬ 
tracts containing 15-30 100% hemolytic units* of hemoly¬ 
sin, death occurred in 24 hours; larger amounts caused 
death within an hour. All of these animals showed 
dyspnea, weakness, prostration, and intravascular hemo¬ 
lysis. The animals which survived 90 minutes showed 
hematuria and considerable enlargement of liver and spleen. 
At autopsy no significant pathological lesions were ob¬ 
served. in animals which survived longer (2-8 hours) 
there was hematuria and, in the majority of animals, 
marked degenerative changes in the tubular epithelium of 
the kidney. The glomeruli revealed no histological changes. 
There was also marked necrosis of the lymphoid cells in 
the follicles of the spleen and small focal necrosis in 
the liver. In animals surviving more than eight hours 
there was almost always marked jaundice, inimals which 
survived for one week showed very little pathologic change 
in the liver, but renal hemorrhages were found. Rabbits 
showed similar changes to those in mice although in smaller 
degree. Guinea pigs were more resistant to the effect of 
hemolysin, no intravascular hemolysis being observed. 
*100% hemolytic unit—That amount of streptolysin S 
which-will cause 100% hemolysis of a .7% suspension of 
human red cells contained in 2 ml. of phosphate-buffered 
saline, pH 7, in 30 minutes at 37°C. 
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Both, the hemolytic and pathologic effects described 
above could be prevented by heating the preparations to 
50°C for 60 minutes. Since the preparations of hemolysin 
used in these studies were not purified, it is impossible 
to attribute with any degree of certainty the lesions 
described to streptolysin S specifically. Other strepto¬ 
coccal products also present in the preparations include 
streptokinase, streptolysin 0, and ribonuclease (RUA-se) 
all of which are susceptible to heating to 50°C for 60 
minutes. In view of the more recent findings on the 
cytopathogenic effects of partially purified albumin- 
hemolysin, or REA-hemolysin on mammalian cells and the 
effect of purified HITA-hemolysin on the basement membrane 
of the kidney (including inhibition by anti-hemolytic 
agents) (70), it may be assumed that at least part of the 
pathological changes induced in the animals described 
above was caused by streptolysin S. 
Todd (78) inoculated two rabbits subcutaneously with 
serum-extracted hemolysin prepared in normal rabbit serum 
from a group A strain. Each rabbit received 24.5 cc. of 
hemolysin--average hemolytic titer approximately 200 100% 
hemolytic units per cc.--in five doses spread over 12 days. 
The rabbits were rested for 146 days before a second course 
of subcutaneous injections was given consisting of 48 cc. of 
hemolysin in 11 doses spread over 25 days. The first rabbit 
died during this course while the second remained well. 
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Two more rabbits were given three courses of serum- 
extracted hemolysin, the first two subcutaneously and the 
third intravenously. The rabbits remained in good con¬ 
dition during the period of inoculation and gained weight. 
Subcutaneous inoculations were followed by local erythema 
and thickening of the subcutaneous tissues at the site of 
injection. Intravenous inoculations did not cause any 
symptoms and there was no evidence of hemoglobinuria. This 
may be due to the relatively low hemolytic titers of serum 
extracted hemolysin. 
Todd (78) attempted immunization of 23 rabbits with 
living cultures of group A hemolytic streptococci. In¬ 
jection of living cultures was usually preceded by I.V. 
Inoculations of vaccine prepared by heating a broth cul¬ 
ture at 56°C for 30 minutes. The animals were then rest¬ 
ed for seven days and immunization was begun by I.V. 
Inoculation of 1.0 cc. of supernatant fluid from a broth 
culture which had been centrifuged for 20 minutes at 3000 
r.p.m. Nine of the rabbits died with hemolytic strepto¬ 
cocci in their blood, four were killed because of arth¬ 
ritis, and ten survived. 
Stollerman at al. (61) injected six rabbits intra¬ 
venously with streptolysin S in a dose of 0.8 mgm. per 
kg. of body weight at each injection. The toxin was 
given twice weekly. Nine injections were given to three 
V' 
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of the animals while three died before the course of in¬ 
jections could be completed. 
Ten rabbits were injected twice weekly, according to 
the schedule outlined by Todd (78), with increasing doses 
of whole culture of living organisms grown in neopeptone 
meat infusion broth for 18 hours at 37°C. Two animals 
died during the first course of injections and one,which 
developed a large orbital abscess, was sacrificed. The 
other rabbits lost weight, appeared ill, and in every in¬ 
stance a fall in serum titer of streptolysin S inhibitor 
occurred, ifter a period of rest, the seven surviving 
rabbits were given a second course of injections similar 
to the first. The second course was tolerated well and 
the animals did not sicken. None exhibited an elevation 
of inhibitor levels, but a reversion to the original nor¬ 
mal levels took place. 
Bemheimer (7) injected 0.10 mgm. streptolysin 3 
(10,000 units/mgm.) intravenously into each of six mice. 
One died in 3 hours, one in 6-g- hours, one in 29 hours, 
two between 32 and 48 hours, and one survived. 0.05 mgm. 
of the same streptolysin S preparation was injected intra¬ 
venously into each of six rabbits. One died in 1 hour 
and five survived. Five rabbits were injected intracu- 
taneously with 1 mgm. streptolysin S (same preparation as 
above). Two of these animals died after the first injection 
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while three survived. Two of the survivors received 
18 injections (total of 180,000 units) at the rate of 
three per week while one received 15 injections (total 
of 150,000 units) also at the rate of three per week. 
Tan, Hackel, and Kaplan (68) observed necrosis of 
renal tubular epithelial cells in mice harboring strep¬ 
tococci in intraperitoneal diffusion chambers. Tan and 
Kaplan (69) found that this effect could be produced by 
the injection of streptolysin S. 
Snyder (59) showed that preparations of the R11A- 
hemolysin were pyrogenic in rabbits and that the pyro- 
genicity could be abolished by lecithin. 
Non-antibody Nature of Serum Streptolysin S Inhibi¬ 
tor: As early as 1949, in the investigation reported by 
Humphrey (33), antistreptolysin 5 failed to conform to 
the accepted definition of an antibody, ][.£. , a gamma¬ 
globulin which combines with an antigen and is produced 
in response to the introduction of the antigen into the 
tissues of the organism. Antistreptolysin S was found to 
occur in the sera of a wide variety of normal animal 
species, in the absence of evidence of either present 
or past streptococcal infection; it did not increase on 
immunization; and the antistreptolysin S activity was not 
located in the gammaglobulin fraction in the sera of humans, 
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rabbits, and horses. 
The highest degree of streptolysin S inhibition 
appears in the fractions associated with alpha-1 and 
beta-1 lipoproteins when serum is fractionated by the 
cold alcohol method. When serum is fractionated by 
salting out with ammonium sulfate, the albumin fraction 
is also associated with streptolysin S inhibition (61). 
Stollerman ejt al. (61) also found that serum phospho¬ 
lipids, particularly lecithin, play an important part 
•in the inhibition, either as components of lipoprotein 
which may inhibit streptolysin 3, or as stabilizing 
agents for lipoprotein complexes, or possibly in both 
capacities. A saline suspension of phospholipids, par¬ 
ticularly lecithin, inhibits streptolysin S. A marked 
reduction of SSI occurs when serum is treated with 
Cl. welchli lecithinase, or with ether or an ether- 
alcohol mixture. Stollerman jet al. concluded that SSI 
in serum appears to be composed of a phospholipoprotein 
complex and that the phospholipids of serum may play 
a role in its stabilization as well as in its composition. 
Relation of Streptolysin S jto Other Streptococcal 
Hemolysins—Interchangeability of the Carriers of the 
Hemolytic Moiety: During the past 30 years several 
oxygen-stable hemolysins have been reported to be 
i' 
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produced in cultures of growing streptococci or in suspen¬ 
sions of resting streptococci. In 1934, Weld (83) showed 
that a potent hemolysin indistinguishable from the hemo¬ 
lysin later described by Todd (78), could be obtained by 
shaking washed streptococci with horse or human serum. 
Todd (78) found that streptolysin S was produced only in 
media containing whole serum. Okamoto (47) and Hosoya et_ 
al. (31)(32) showed that yeast nucleic acid induced the 
formation of a potent hemolysin in growing streptococcal 
‘cultures. Studies by Bemheimer (4) (5), Hosoya and his 
collaborators (31)(32), and Tanaka, Hayashi, and Maekawa 
(71) showed that the digestion of yeast RNA with pancreatic 
ribonuclease markedly increased its hemolysin-inducing 
capacity. 
In 1956 Schwab showed that hemolytic material can be 
obtained from streptococci subjected to sonic energy for 
long periods of time (53)(54). The hemolytic material was 
named intracellular hemolysin. Schwab reported (55) that 
the intracellular hemolysin is antigenic in rabbits, and 
thus may be different from streptolysin 3. The nature of 
this material and its possible relationship to the RITA or 
serum hemolysin remains to be established. 
In 1958 Ginsburg and Grossowicz (16) showed that 
various strains of group A streptococci possess a cell- 
bound hemolysin. This hemolysin, which may be identical 
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with that described by Weld (83), could not be released 
from the cells by sonic disruption or by grinding with 
glass beads (16), but was released by treatment with 
serum albumin, Tween-40, -60, -80, or Triton X-205 (16). 
The problem of the role played by such diverse ma¬ 
terials and substances as serum, albumin, detergents, and 
RUA in the induction of hemolytic activity from resting 
streptococci was studied by Ginsburg and Harris (20). 
They proposed the concept of a carrier-hemolysin complex 
on the basis of their studies. Their experiments showed 
transfer of hemolysin from one carrier to another, in¬ 
activation of the respective hemolysins by proteolytic 
degradation of the hemolytic moiety or by hydrolysis or 
distortion of the carrier molecule, inhibition of the 
hemolytic activity of all the hemolysins by the same 
inhibitors, the lack of all these hemolysins in a single 
streptococcal mutant, and the non-antigenicity of all these 
hemolysins. These observations lead to the conclusion 
that a single hemolytic group synthesized by streptococci 
can be bound by a variety of carriers which have affinity 
for that active group. 
This work also sheds new light on the cell-bound 
hemolysin of streptococci (83)(16), and its relation to 
the various forms of extracellular hemolysin described. 
During the growth of the streptococci in media devoid of 
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any of the carriers mentioned above, the hemolysin is 
synthesized and is found closely associated with the 
bacterial cell. Upon addition of a substance which has 
greater affinity for this hemolysin than does the strep¬ 
tococcal cell-component involved, the hemolysin is re¬ 
leased from the cells to form a complex with this sub¬ 
stance. (20). 
As to the chemical nature of the carrier essential 
for the induction or binding of hemolysin, at least three 
“families of compounds may be involved; first, lipids, 
phospholipids, or fatty acids; second, RITA or RITA core; 
third, substituted oxyethylene polymers, as Triton X-205 
and Tweens. Ginsburg and Harris concluded that these 
hemolysins represent a single hemolytic group synthe¬ 
sized by streptococci, which can be bound to a number of 
carriers, the original carrier being a component of the 
streptococcal cell. 
Possible Reasons for the Non-antigenicity of Strep¬ 
tolysin S: Possible reasons for the non-antigenicity of 
streptolysin S are its small size (molecular weight, 12,000, 
for the whole lysin or polypeptide-polyribonucleotide com¬ 
plex, as determined by gel filtration) (8) and the 
looseness of the binding of the polypeptide to the poly¬ 
ribonucleotide as shown by the possibility of transfer of 
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the hemolytic moiety from one carrier to another (20). 
According to Koyama (4l) the weight ratio of polypeptide 
to polyribonucleotide of highly purified streptolysin S 
is 0.3:1. Therefore, if streptolysin S (polypeptide plus 
polyribonucleotide) has a molecular weight of 12,000 the 
molecular weight of the polypeptide, the active moiety, 
is 2,800, and it should consist of approximately 28 amino 
acid residues. 
Antigenicity of Low Molecular Weirht Substances: 
Antigenicity is usually hindered by low molecular weight. 
However, in recent years several examples of antibody pro¬ 
duction to low molecular weight substances (even without 
recourse to a carrier) have been reported in the litera¬ 
ture. It is remarkable that Axelrod, Trakatellis, and 
Hofmann have found that biologically inactive peptides 
with a chain-length of 16 amino acids (molecular weight 
less than 2000) are immunogenic (1). Sela, Fuchs, and 
Arnon showed synthetic polyamino acids, of molecular 
weight around 4000, to be immunogenic, provided that they 
were of certain composition and contained certain amino 
acid sequences (56). Antibodies have been produced 
against synthetic oxytocin, an octapeptide, by Gilliland 
and Prout (15). This evidence of antigenicity of low 
molecular weight substances is in no way contradictory 
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to the well-established observation that antigenicity 
increases with increasing molecular weight. Even in the 
low range of molecular weights the same rule applies: 
Axelrod et. al. found that immunogenicity of small pep¬ 
tides increases with increase in chain length. In their 
experience a peptide consisting of 20 amino acids was more 
\ 
immunogenic than a peptide consisting of 16 amino acids 
(1). 
Methods to Make Antigenic Substances That are Not 
Naturally So: At an increasing pace in recent years, 
antibodies have been produced to substances which are not 
naturally antigenic by a number of chemical and physico¬ 
chemical maneuvers. Some of these maneuvers are relevant 
to the problem at hand. 
Historically, Landsteiner*s pioneer investigations 
on the antigenicity of low molecular weight substances 
are noteworthy. His demonstration (45) that an organic 
molecule of low molecular weight, e..£., ascorbic acid, 
functions as a hapten, when it is linked covalently to 
a protein antigen as a carrier, opened up a new avenue 
for the study of antibody formation and structure. 
Goodfriend, Levine, and Fasman (23) produced anti¬ 
bodies to the low molecular weight polypeptides brady- 
kinin and angiotensin. They used water soluble caroo- 
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diimides as coupling agents to produce hapten-protein 
conjugates, e_.s^., bradykinin-rabbit serum albumin (ESA), 
in which case bradykinin is the hapten and rabbit serum 
albumin is the protein. 
Butler, Beiser, and Erlanger (9) and Tannenbaum and 
Beiser (75) showed that purine and pyrimidine bases are 
haptens when coupled to a protein such as bovine serum 
albumin and that antibodies to the haptens react with 
denatured PITA. In addition Goebel and Avery (22) had 
demonstrated that pneumococcal polysaccharides, which 
are non-antigenic in the rabbit by themselves, could act 
as haptens when coupled to a protein. Plescia, Braun, 
and Palczuk were motivated by these observations to 
further immunochemical studies or chemically defined 
DNA-protein complexes. They succeeded in producing anti¬ 
bodies to denatured PEA by utilizing a complex consisting 
of denatured PEA and methylated bovine serum albumin (MBSA) 
(48). 
RATIONALE 
It is known that streptolysin S consists of two dis¬ 
tinct portions, polypeptide and polyribonucleotide. The 
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polypeptide portion is an acidic polymer because it is 
rich in glutamic acid and has a low content of basic 
amino acids (41). In light of the work of Plescia et 
al, (48) with denatured DNA and methylated bovine serum 
albumin (MESA) it seemed reasonable to try to make a com¬ 
plex of streptolysin S and MBSA, a basic protein, which 
presumably would interact electrostatically just like 
denatured DNA and MBSA. 'The MESA would act as a carrier 
protein. In this way one might be able to make strepto¬ 
lysin S antigenic., 
On addition of MESA to streptolysin S a precipitate 
formed and experiments were then conducted to determine 
what happened to the streptolysin S hemolytic activity. 
Was the hemolytic activity precipitated? Did any hemo¬ 
lytic activity remain in the supernatant? If the hemo¬ 
lytic activity was precipitated, could it be recovered? 
If the last possibility were the case one could infer 
that the configuration of the streptolysin S molecule was 
maintained in an unaltered form in the precipitate. 
An attempt was also made to produce antibodies to 
RNA and RITA core according to the method of Plescia et, 
al. (48). Since RITA core is part of the polypeptide- 
polyribonucleotide complex which goes under the name of 
streptolysin S, it was hoped that such antibodies would 
cross react with streptolysin S and inhibit it. In this 

regard it is noteworthy that streptolysin S is not com¬ 
mercially produced and its production is tedious and 
time-consuming. Most of the streptolysin S lots used 
in these studies were prepared in Dr. Taranta’s labor¬ 
atory. RilA and RN.A core are both produced commercially, 
and therefore, are readily available. 
Because of the success of Goodfriend e_t al. in 
production of antibodies to the low molecular weight 
polypeptides bradykinin and angiotensin with the use 
•of soluble carbodiimides as coupling agents (23), and 
because streptolysin S is known to have a polypeptide 
portion, an attempt was made to produce antibodies to 
streptolysin S by immunizing a rabbit with streptolysin 
S coupled by l-ethyl-3-(3-dimethyl-aminopropyl) carbo- 
diimide hydrochloride ("Ethyl CDI") to rabbit serum al¬ 
bumin (RSA). By analogy with GoodfriendTs work it was 
assumed that the carbodiimide would act as a transient 
carrier for M3S.4, followed by replacement of the carbo¬ 
diimide by streptolysin S, and formation of a peptide 
bond between the latter and MBSA. 
During the course of this investigation it was found 
that streptolysin S when passed through a Seitz filter 
was bound to the filter and could be eluted from it by 
solutions of high ionic strength. Because of this chance 
observation immunization attempts were made using a Seitz 
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filter impregnated with streptolysin S. The filter 
served as a "carrier" for the streptolysin S as well as 
an "adjuvant" (irritant). 
METHODS AND MATERIALS 
Streptolysin S: Streptolysin S was prepared by Worthing¬ 
ton Biochemical Corp. and in Dr. Taranta's laboratory 
according to the method of Bemheimer (5) with modifica- 
’tions suggested by Ginsburg (19). The hemolysin was stored 
in the lyophilized state and was dissolved in streptolysin 
S buffer just before use. 
Streptolysin S Buffer: Streptolysin S buffer was prepared 
according to the method described by Bemheimer (5). 
Stock Erythrocyte Suspension: The stock erythrocyte sus¬ 
pension was prepared according to the method described by 
Bemheimer (3). 
Methylated Bovine Serum Albumin: Methylated bovine serum 
albumin was prepared according to the method of Sueoka and 
Cheng (63). 
Adjuvant: Complete Freund*s Bacto Adjuvant was obtained 
from Difco Labs. 
Measurement of Hemolytic Activity: The hemolytic activity 
was titrated according to the method of Bemheimer (3). 

24 
One unit of streptolysin S is defined as that amount 
of hemolysin which will cause 50^ hemolysis of a ,7% 
suspension of human red blood cells contained in 2 ml. 
of phosphate-buffered saline, pH 7, in 30 minutes at 
37°0. 
Standard Method for Titration of Serum Inhibitory 
Activity Against Streptolysin S: Serum inhibitory 
activity against streptolysin 3 was determined accord¬ 
ing to the method of Stollerman and Bernheimer (60). 
■Preparation of Ouchterlony Plates: (as in the labora¬ 
tory of S. Halbert, and essentially as follows): 4.25 
grams sodium chloride were dissolved in 500 ml. dis¬ 
tilled water. 2.5 grams Ionagar N:2 were added and the 
suspension was boiled until all the agar was dissolved. 
Solid sodium veronal, 4.13 grams, was then added, followed 
by solid glycine, 7.5 grams. After the last two ingred¬ 
ients were dissolved the solution was cooled to 60°C. 
After 50 mgm. methiolate (1:10,000) was added, the pH was 
adjusted to 7.7 at 60°C with 5N HC1 or 5N NaOH. The pH 
shifted to 7.4 on cooling to 20°C. The agar was stored 
in Erlenmeyer flasks and liquefied and poured into Petri 
dishes when needed. Holes were cut with a pattern cutter. 
Modification of Farr Technique: The Farr technique has 
been published previously (12)(13). The essential re¬ 
quirement for use of the Farr technique is that the 

25 
antigen in question not be precipitated by saturated 
ammonium sulfate. Radioactive antigen which is custom¬ 
arily used in this technique has not been employed in 
the present study. Instead, the supposed antigen, 
streptolysin S, possesses a specific biologic activity 
of its own. Its presence can be detected by hemolytic 
titration. 
i 
Rabbits: All rabbits used in this study were New Zealand 
white male albinos, 7-8 pounds. 
■Ribonuclease; Ribonuclease was obtained from Worthington 
Biochemical Corp. (lot # R-547). 
Trypsin: Trypsin was obtained from Worthington Biochemical 
Corp. (lot § TR558SF). 
Rabbit Serum Albumin; Rabbit serum albumin was obtained 
from pentex, Incorp. (lot § 9). 
Carbodlimide: l-ethyl-3-(3-dimethyl-aminopropyl) carbo- 
diimide hydrochloride ("Ethyl CDI") was obtained from the 
Ott Chemical Co. 
Ribonucleic Acid: Ribonucleic acid (yeast) was obtained 
from Worthington Biochemical Corp. (lot # RNA 7DB). 
Ribonucleic Acid Core: Ribonucleic acid core was obtained 
from Worthington Biochemical Corp. (lot # RNAC 632). 
Milllnore Filter: Millipore filters were obtained from 
the Millipore Filter Corp. Specifications were GSWP 
047 00, GS 0.22u, white, plain, 47 mm. 
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Seitz Filter: Seitz filters were obtained from Republic 
Seitz Filter Corp. Specifications were SI sterilizing #6 
pore size 0.2u, diameter 60mm. 
EXPERIMENTAL 
i 
Immunization with Streptolysin 3 and Methylated 
Bovine Serum Albumin: 10 mgm. MBSA was dissolved in .5 
ml. distilled water in test tube #1 which was then placed 
in an ice bath. In test tube #2, 4 mgm. streptolysin S 
was dissolved in .5 ml. streptolysin S buffer which had 
been pre-ccoled in an ice bath. The MBSA solution was 
added to the streptolysin S solution followed by the im¬ 
mediate formation of a milhy white precipitate. This 
new suspension was titrated for hemolytic activity. The 
results of all titrations for injections in the SS-MBSA 
immunization experiment are in Table I. 
One ml. of adjuvant was then added to the S3-MBSA 
suspension and a smooth emulsion was prepared by thorough 
mixing. The next step was the injection of a rabbit with 
this preparation. All injections were intramuscular be¬ 
tween the scapulae. Although the original solutions 
totaled 2 ml. (.5 ml. streptolysin S in buffer plus .5 
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ml. MBSA in distilled water plus 1 ml. adjuvant) approxi¬ 
mately 1.5 ml. remained after complete mixing with the 
adjuvant. 
Table ! 







1 1 76,000 less than 80 
1 2 90,000 less than 80 
1 3 96,000 less than 80 
1 4 108,800 not done 
3 1 42,000 290 
3 2 105,000 550 
3 3 125,000 750 
3 4 108,800 not done 
4 1 105,000 550 
4 2 125,000 750 
4 3 240,000 3,600 
4 4 108,800 not done 
In an alternate method for the preparation of strep¬ 
tolysin S for immunization the heat lability of the toxin 
was considered. This lability is not due to oxidation, 
and it is not due to surface inactivation. Bernheimer 
found that potassium ions protect streptolysin S against 
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thermal inactivation (6) thus decreasing its heat lability. 
Because of this observation KC1 was utilized in some of 
the immunization attempts. The method was similar to that 
detailed above except for the following points. KC1 was 
added to the streptolysin S solution before the MBSA 
solution was added. To the .5 ml. streptolysin S solution, 
150 mgm. KC1 was added. As can be seen in Table I, more 
hemolytic activity was preserved after the addition of 
MBSA when KC1 was utilized (rabbits 3 and 4) than in the 
absence of KC1 (rabbit 1). After this new solution was 
titrated for hemolytic activity the MBSA solution was added 
and the remainder of the procedure was completed (as de¬ 
tailed above). 
Rabbit 1 was given a series of three injections of 
the SS-MBSA product. Rabbit 2 was used as a control and 
was injected with only MBSA. 10 mgm. MBSA was dissolved 
in 1 ml. distilled water. To this solution 1 ml. adju¬ 
vant was added and the two were mixed. Rabbits 3 and 4 
were injected three times with streptolysin S to which 
KC1 had been added plus MBSA. All injections were given 
at weekly intervals. 
Each rabbit was bled before any injections had been 
given. from the date of the first injection the rabbits 
were bled daily (4 ml. each bleeding) for three weeks 
(until one week after the third injection had been given). 
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Daily bleedings were performed because we were not only 
interested in an antibody response but also in possible 
changes in streptolysin S inhibitor (SSI) levels. The 
serum from each sample was separated and was frozen at 
-4°C. ifter all sera were collected for a given rabbit, 
the anti-hemolytic activity of the pre- and post-injection 
sera was determined. 
The results of the anti-hemolytic activity determi¬ 
nations are presented in figure 1. It is clear from this 
.data that there was no significant change in the anti- 
hemolytic activity of the post-injection sera when com¬ 
pared with the pre-injection serum. 
With the above approach only those antibodies directed 
against the hemolytic site may be presumed to be detected. 
It is possible to hypothesize antibodies against other 
parts of the molecule which under the conditions of this 
system would go undetected since no precipitate is formed. 
Because of this possibility, other approaches were utilized 
in an effort to detect the presence of antibodies against 
streptolysin S. 
The plate method of Ouchterlony gave the following 
results (Figure 2). The plate illustrated below is repre¬ 
sentative of all plates for post-injection sera from rab¬ 


















FIGURE 2—Ouchterlony plate showing the reactivity 
of serum (21 days after injection 4) from rabbit 4 
injected with streptolysin S-MBSA complex: 
1. streptolysin S, 10 mgm./ml.; 2. EE A core, 10 
mgm./ml.; 3. RKA-se, 0.01 mgm./ml.; 4. EE A, 10 
mgm./ml.; 5. MBSA, 10 mgm./ml.; 6. MESA, 1 mgm./ml.; 
7. Serum. 
Precipitates formed between the center well (7) and 
wells 1, 2, and 3 with a reaction of identity between them. 
Since RNA-se is used in the preparation of EE A core and 
REA core in the preparation of streptolysin S, the con¬ 
clusion appears justified that the antibody here detected 
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Is directed against RKA-se just as in the immunization 
experiments with RNA core to be described later. Using 
this system, no antibodies were detected in post-injection 
sera from rabbit 2. ho precipitating antibodies directed 
against MBSA were present in any of the post-injection 
sera (rabbits 1 through 4). 
To detect the possible presence of non-inhibiting 
and non-precipitating antibodies, a third method was used, 
a modification of the Parr technique (12) (13). With this 
method one may be able to precipitate such antibodies 
bound to streptolysin S. The protocol presented below 
was arrived at after several preliminary experiments. 
This experiment was performed with representative sera 
taken from rabbits 1, 3, and 4. Tubes 1 through 6* were 
prepared as indicated in Table II. 
After thorough mixing, tubes 1 through 6 were incu¬ 
bated at 4°C for 24 hours while tubes 1* through 6' were 
incubated at 37°C for 30 minutes. After incubation both 
sets of tubes were treated similarly. 2 ml. saturated 
ammonium sulfate solution was added to tubes 1, 3, and 
5 and 1T, 3', and 5f. At the same time 2 ml. streptolysin 
S buffer was added to tubes 2, 4, and 6 and 2', 4’, and 
6*. All of these tubes were mixed, incubated at 4°C for 
30 minutes and then centrifuged at 1500 rpm for ten 
minutes. The supernatants were then titrated for hemolytic 

activity. The results of a typical experiment are 
presented in Table III (on page 34). 
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Table II 
Tube Streotolysin S ITormal Post- Streotolysin S 
600 units/ml. Serum* injection 
Serum* 
Buffer 
1 1 ml. 1 ml. — — 
- 1* 1 ml. 1 ml. — — 
2 1 ml. 1 ml. — — 
2* 1 ml. 1 ml. — — 
3 1 ml. — — 1 ml. 
3* 1 ml. — — 1 ml. 
4 1 ml. — — 1 ml. 
41 1 ml. — — 1 ml. 
5 1 ml. — 1 ml. — 
5* 1 ml. — 1 ml. — 
6 1 ml. — 1 ml. — 





Part A— Incubated at 4°C for 24 hours. 










600 210 35 % 
2 normal 
serum 
600 320 53% 
3 Streptolysin 
S buffer 
600 385 64% 
4 Streptolysin 
S buffer 
600 490 82% 
5 Post-injection 
serum* 
600 320 53^ 
6 Post-injection 
serum 
600 350 58% 
Part B—Incubated at 37°C for 30 minutes. 










600 240 40% 
2' Normal 
serum 
600 280 47% 
3* Streptolysin 
S buffer 
600 190 32 % 
4* Streptolysin 
S buffer 
600 255 42% 
5' Post-injection 
serum 
600 230 58% 
6* Post-injection 600 330 55% 
serum 
* Rabbit 4, 21 days after injection 4. 
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The basic point to be noted is that there was no 
decrease in recovery of hemolytic activity in the immune 
serum-with respect to recovery in the normal serum. 
Although normal serum and immune serum with saturated 
ammonium sulfate solution yielded a lower recovery of 
hemolytic activity than did comparable tubes without 
ammonium sulfate, the same phenomenon was observed in the 
control tubes which contained streptolysin S buffer in 
place of serum (tubes 3 and 3'). Therefore, this decrease 
in hemolytic activity cannot be explained on the basis of 
precipitation of complexes consisting of serum constitu¬ 
ents (antibody or otherwise) and streptolysin S by 
ammonium sulfate solution. 
Precipitation of Streptolysin S by; Methylated Bovine 
Serum Albumin and Its Recovery from the Precipitate: 
Because of the absence of an antibody response in the 
previous experiment, the question arose whether strepto¬ 
lysin S was destroyed in the preparation of the 3S-MBSA 
complex. This possibility was explored by the following 
experiment. 
10 mgm. MBSA was dissolved in 0.5 ml. distilled 
water and 4 mgm. streptolysin S (19,600 units/mgm., 78,400 
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units total) was dissolved in 0.5 ml. streptolysin S 
buffer. The solutions were prepared in an ice bath and 
on mixing the two a precipitate formed immediately. The 
suspension was centrifuged and the precipitate washed 
twice with 4 ml. streptolysin S buffer (diluted 1:2 with 
distilled water). The hemolytic activity of the super¬ 
natant and the washings was less than 20 units. 
The precipitate was resuspended in 1.5 ml. strepto¬ 




















2 ml. streptolysin S buffer 
2 ml. rabbit serum (unheated) 
2 ml. phosphate buffer, pH 9.5 
Controls 
S Additional Contents 
2 ml. streptolysin S buffer 
2 ml. rabbit serum (unheated) 
2 ml. phosphate buffer, pH 9.5 
All suspensions were incubated for one hour at 37°C 
and were then centrifuged. Hemolytic activity of the 
supernatants was assayed with red blood cells from the 




The hemolytic activity of tubes 1 through 6 is pre¬ 









Hemolytic Activity (units/ml.) 






* Ho hemolysis at 1:20 dilution. 
** 6,850 (hemolytic units/ml.) x 2.5 (ml./test tube) x 3 
(number of test tubes) - 51,375 units. Thus, 65/5 of 
the initial activity can be recovered with the 
extraction procedure used for tube 3. 
The finding that streptolysin S hemolytic activity 
could be recovered in such high yield from the precipi¬ 
tate which formed when streptolysin S and MESA were mixed 
is direct evidence that the bulk of streptolysin 3 was 
not destroyed in the preparation of the SS-MBSA complex. 
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Determination of Optimal Ratio of Ribonucleic Acid, 
Ribonucleic Acid Core, and Streptolysin S to_ Methylated 
Bovine Serum Albumin for Immunization Procedures: The 
following experiments were performed to establish whether 
the ratio of streptolysin S to MBSA utilized in the SS-MBSA 
immunization experiment was an ideal one, i .e.., whether the 
complex prepared was as rich as possible in streptolysin S. 
Since streptolysin S was available in very limited amounts 
immunization efforts with complexes consisting of MBSA with 
RITA and RNA core respectively were also planned. Therefore, 
additional experiments were performed to determine optimal 
ratios of RITA and RITA core to MBSA for immunization. 
Varying amounts of R1IA dissolved in .5 ml. streptolysin 
S buffer were added to each of seven test tubes as indicated 
in Table VI. On the addition of a constant amount of MBSA 
to each tube a precipitate formed immediately. The new 
suspension was incubated in an ice bath for ten minutes. 
Then the tubes were centrifuged, and the optical density of 
the supernatants at 260 mjji and 280 m^ was determined 
(Table VI). The object of this procedure was to find the 
minimum amount of RITA necessary to combine with all of the 
MBSA (said another way, to find the largest amount of RITA 
which could be completely precipitated by .5 mgm. MBSA). 
By determining the O.D. of the supernatants at 260 mjji and 
280 mjj any MBSA or RITA remaining in the supernatants after 

FIGURE 3 - Optical density at 260 ip and 280 mpi of super 
natants of RHA - MESA precipitates. The amount of MB3A was 
lcept constant (.5 mgm. ). The amount of REA varied and is 
indicated on the abscissa: optical density at 260 mu,° o; 
optical density at 200 mp, Q—®. 
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hemolytic activity (Table VIII). 
Table VII 
Tube Mem. RITA 
in .2 ml 
buffer 
core Mem. MBS A in 






A 1.25 .5 52.4 24.0 
B .94 .5 36.4 16.6 
C .625 .5 21.6 9.8 
D .31 .5 7.3 3.2 
S .16 .5 3.4 1.8 
P .08 .5 2.5 1.7 
G .04 .5 3.3 2.1 
Table VIII 
Tube Units of SS Mgm. SS Mem. MBSA Recovery O.D. O.D. 
in .2 ml. 
SS buffer 
in .2 ml. 
distilled 




water mu mu 
A 20,000 1.25 .5 8,000 29.2 14.8 
B 15,000 .94 .5 4,500 21.6 11.0 
G 10,000 .6 25 .5 180 10.5 5.2 
D 5,000 
.31 .5 8 3.4 2.0 
E 2,500 .16 .5 9.2 2.3 1.5 
P 1,250 .08 .5 33.2 2.2 1.7 
G 625 .04 .5 36 2.4 2.0 
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FIGURE 4- - Optical density at 260 mp and 280 mp of super¬ 
natants of RNA core - MB3A precipitates. The amount of MB3A 
was kept constant (.5 mgra.). The amount of RNA core varied 
and is indicated on the abscissa: optical density at 260 mfJ, 
o~ ° ; optical density at 280 mp. ® ©. 
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S necessary to combine with all of the MBSA (said another 
way, to find the largest amount of streptolysin S which 
could be precipitated by .5 mgm. MESA). As seen in 
Figure 5, the low point with respect to hemolytic activity 
present in the supernatants falls at .31 mgm. streptolysin 
S (tube D). On the basis of this experiment the optimal 
ratio of streptolysin S to MESA was calculated to be .3 
mgm. streptolysin 3 to .5 mgm. MESA or .6 : 1.0. 
The optimal ratio of streptolysin S to MESA (also RITA 
‘and RiTA core to MESA) arrived at in this experiment (.6 to 
1.0) is similar enough to the ratio employed in the SS-MBSA 
immunization experiment (.4 to 1.0) to conclude that the 
ratio used was an adequate one. On the basis of these 
results the immunization efforts with RNA and RITA core will 
utilize the ratio .6 to 1.0 (REA:MBSA and RNA coreiMBSA). 
Immunization with Ribonucleic Acid: QO mgm. MESA 
was dissolved in .75 ml. distilled water and 50 mgm. RITA 
was dissolved in .75 ml. streptolysin S buffer, both at 
room temperature. After the MESA solution was added to 
the RUA solution a milky white precipitate formed immedi¬ 
ately. The new product (1.5 ml.) was mixed with 1.5 ml. 













FIGURE 5 - Optical density at 260 mp and 280 mp and hemolytic 
activity of supernatants of streptolysin S - MBSA precipitates. 
The amount of MBSA was kept constant (.5 mgm.). The amount 
of streptolysin S varied and is indicated on the abscissa: 




into each of two rabbits (333, 334) as follows: (all 
injections were subcutaneous) ,5 nl. in bach and front 
of neck; .5 ml. in each of four foot pads. Both rabbits 
were bled pre- and post-injection (day 0, 8, 16, 26, 34, 
37, 48). 
All sera were tested for their titer of inhibitory 
activity against streptolysin S by the standard method. 
The results presented in Figure 6 show only minor variations 
in inhibitory titer which are not suggestive of an antibody 
.response. 
All sera were tested on Ouchterlony plates as illus¬ 
trated in Figure 7. Under these conditions the post¬ 
injection sera from rabbit 333 showed no antibody response. 
Pre-injection serum from rabbit 334 showed a line of pre¬ 
cipitation with RITA core. On the eighth post-injection 
day the line of precipitation between serum and RITA core 
took longer to appear. On the ninth post-injection day a 
line appeared between the serum and the RITA which by day 
16 had become more evident than the RITA core line. Finally 
by day 34 a suggestion of a double precipitating system 
appeared against RITA and RRA core (with a reaction of 
identity in each of the lines). This would indicate the 
presence of antibodies against two distinct constituents 
















complexes (333 and 33^) in complete Freund's adjuvant. 
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FIGURE.?*—Ouchterlony plate showing the reactivity 
of serum (post-injection day 34) from rabbits 333 and 
334, both injected with RNA-MBSA complex: 1. serum, 
rabbit 333; 2. R21A core, 10 mgm./ml. ; 3. RITA core, 
10 mgm./ml.; 4. serum, rabbit 334; 5. RRA-se .01 mgm./ 
ml.; 6. RRi-se, .01 mgm./ml.; 7. RITA, 10 mgm./ml. 
The first two rabbits immunized with RHA died a few 
months post-injection. Four more rabbits were immunized 
exactly as described above. The sera were tested for their 
titer of inhibitory activity against streptolysin S by the 
standard method. The results are not suggestive of an anti¬ 
body response. Ouchterlony plates showed no evidence of 
an antibody response against EIA, 
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Immunization with. Ribonucleic Acid Core: The details 
of this procedure were the same as those in the immuni¬ 
zation with ribonucleic acid except for the substitution 
of RNA core for RITA (rabbits 81 and 82). 
All sera were tested for their inhibitory titer 
against streptolysin S by the standard method. The results 
presented in Figure 6 show only minor variations in the 
inhibitory titer which are not suggestive of an antibody 
response. 
All sera were tested on Ouchterlony plates as illus¬ 
trated in Figure 8. Under these conditions both rabbits 
showed a line of precipitation between serum and RNA core 
and serum and RNA-se which was present on the twenty-sixth 
post-injection day in rabbit 81 and on the sixteenth post¬ 
injection day in rabbit 82. These lines for both rabbits 
showed a reaction of identity. Thus, the antibody formed 
was against a constituent present in both RITA core and 
RNA-se. The most likely possibility is that the antibody 
was against RNA-se which is used in the preparation of 
RITA core and, therefore, is a likely contaminant. 
The two rabbits immunized with RNA core (81 and 82) 
were re-injected with an RNA core - MESA complex six months 
after the initial set of injections and an additional two 
rabbits were given their first set of injections. The 




and all sera were tested for their inhibitory titer 
against streptolysin S by the standard method. The 
results are not suggestive of an antibody response. 
FIGURE 8--Cuchterlonyvplate showing the reactivity 
of serum (post-injection day 26) from rabbit 81 
and of serum (post-injection day 16) from rabbit 
82, both injected with REA cere - MESA complex: 
1. serum, rabbit 81; 2. REA core, 10 mgm./ml.; 
3. REA core, 10 mgm./ml.; 4. serum, rabbit 82; 
5. REA-se, 0-.1 mgm./ml.; 6. REA-se, 0.1 mgm./ml.; 
7. REA, 10 mgm./ml. 

All sera were tested on Ouchterlony plates and 
showed lines of precipitation 
(Figure 9). These lines gave 
As stated previously the most 
that the antibody was against 
with RNA core and RNA-se 
a reaction of identity, 
likely possibility is 
RNA-se. 
FIGURE 9—Ouchterlony plate showing the reactivity 
of serum (three and four weeks post-injection) from 
rabbit 82, injected with RHA core - MBSA complex: 
1. post-injection serum, day 21; 2. RITi-se, 0.1 
mgm./ml.; 3. RNA-se, 0.1 mgm./ml. ; 4. post-injection 
serum, day 28; 5. RNA, 10 mgm./ml.; 6. RITA, 10 
mgm./ml.; 7. RNA core, 10 mgm./ml. 
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Immunization with Streptolysin S and Rabbit 3erum 
Albumin Coupled by a Carbodiimide; 10 mgm. rabbit serum 
albumin (RSA) and 10 mgm. streptolysin 3 were dissolved 
in 0.5 ml. distilled water in an ice bath. To this 
solution .25 ml. water containing 200 mgm. ethyl CDI was 
added. The reaction between ethyl GDI and the streptoly¬ 
sin S - RSA mixture was allowed to tahe place at room 
temperature with gentle agitation for 50 minutes. The 
reaction was terminated by dialysis against distilled 
water for 24 hours in the cold. Indirect evidence of 
successful conjugation was the formation of a precipitate 
within 24 hours. Both the precipitate and the soluble 
material were suspended in an equal amount of Freund*s 
adjuvant and the resulting emulsion was used for immuni¬ 
zation. 
A single rabbit was injected intramuscularly and 
subcutaneously twice, 51 days apart. The rabbit was 
bled before the first injection and on post-injection days 
21, 51, and 50. In an effort to demonstrate antibodies 
directed against the hemolytic site of streptolysin S, 
the anti-hemolytic activity of the pre- and post-injection 
sera was determined. There was no detectable increase in 
the anti-hemolytic activity of the post-injection sera 
when compared with the pre-injection serum. 
? A second attempt to detect antibodies to streptolysin S 
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utilized gel diffusion on Ouchterlony plates. With this 
method one could identify any precipitating antibody to 
streptolysin S whether or not the antibody was directed 
against the hemolytic portion of the molecule. The 
results of the gel diffusion test are presented in figures 
10 and 11. 
1 
FIGURE 10—ouchterlony plate (I) showing the 
react*vity_of serum from a rabbit injected with 
s S “ 7 ?Si.?ocPlsx: I- pre-injection 
d'afso-0? Sstr mUdW ?ls 4. post-injection L™, 
B^emic^hoo^? S’ 5 '^thinghn 
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FIGURE 11-—Ouchterlcny plate (II) showing the 
reactivity of serum from a rabbit injected with 
streptolysin S - RSI complex: 1. pre-injection 
serum; 2. post-injection serum, day 21; 3. post¬ 
injection serum, day 31; 4. post-injection serum, 
day 50; 5* streptolysin S, 5 mgm./ml.> Or. 
laranta’s laboratory. 
There were two bands of precipitation on Flate I between 
the central well (5) and well 4. Plate II had one band 
of precipitation between the central well (5) and well 
4. There were no other lines of precipitation on either 
plate. Thus, antibodies were present in serum from post¬ 
injection day’50 against two distinct antigens present in 
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the Worthington Biochemical Corp. streptolysin S 
preparation. This same serum contained antibodies 
against one antigen present in the streptolysin 3 pre¬ 
pared in Dr. Taranta’s laboratory. To find out whether 
one of these antigens was streptolysin S itself, the 
following experiment was carried out. 
Streptolysin S was added to pre- and post-injection 
sera in an amount sufficient to form a visible precipi¬ 
tate in the latter. After incubation in the cold over- 
night; the precipitates were centrifuged out and the 
supernatants were titrated for hemolytic activity. There 
was no decrease of hemolytic activity in the supernatant 
of the post-injection serum as compared to that of the 
pre-injection serum. Therefore, it was concluded that the 
antibodies present in the post-injection serum were not 
against streptolysin 3 itself, but rather against impuri¬ 
ties present in the streptolysin 3 preparations used. 
(By analogy with the results obtained on immunization 
with the streptolysin S-MBSA complex and with the RITA 
core-MBSA complex, one may surmise that one of the anti¬ 




Seitz Filtration of Streptolysin S and Extraction 
of Streptolysin S Hemolytic Activity by Hirh Ionic 
Strength Solutions: 35 ml. non-dialyzed streptolysin 
S was passed through a Seitz filter in 5 ml. aliquots. 
This was followed by 30 5 ml. washings with the medium 
used for the preparation of streptolysin S less maltose, 
cysteine and ENA core. Finally eight 5 ml. aliquots of 
each of the following solutions were passed through the 
filter successively: medium described above plus .5% 
NaCl, 1% Nad, 2% Nad, k% Nad, 8% Nad, 16% Nad and 
a saturated solution of Nad respectively. Each 5 ml. 
aliquot was collected separately and titrated for hemo¬ 
lytic activity. Then the optical density was determined 
at 260 mju and 280 m/i. The results of a typical experiment 
are presented in Figure 12. 
The total amount of hemolytic activity passed through 
the Seitz filter was 224,000 units. The recovery in the 
eluates was 126,500 units or 56^. The recovery of 260 mu 
absorbing material was 93/£ and the recovery of 280 mju 
absorbing material was 54^. 
Immunization with Streptolysin S Bound to a Seitz 
Filter: A Seitz filter with streptolysin S bound to it 













260 mjM , -’o ; optical density at 280 m/u,®-« ; hemolytic units, 
11:1 0 • f'be 1 is unfiltered streptolysin S. 

57 
rabbits. A control rabbit was implanted with only a filter 
free of streptolysin S. The details of the procedure are 
presented below. See Table IX for the number of units of 
streptolysin S bound to each filter. 
Table IX 











The following procedure was conducted under sterile 
conditions (except for rabbits 331 and 332). Tor each 
rabbit an average of 30 ml. non-dialyzed streptolysin S 
was passed through a sterile Millipore filter to rid the 
streptolysin S preparation of any streptococci still pre- 
Preparation of the Seitz filter for these rabbits 
was not performed under sterile conditions. 
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sent. The streptolysin S was then passed, through a 
sterile Seitz filter in 5 ml. aliquots. .All solutions 
used for washing were first passed through a sterile 
Millipore filter. After the streptolysin 3, 30 5 ml. 
washings with the medium described in the previous section 
were passed through the Seitz filter followed by eight 
5 ml. aliquots of the same medium with .3% had added 
and eight with 1% NaCl added. All solutions passed through 
the filter were kept in an ice bath before use. All fil¬ 
trates were disposed of. 
Under sterile conditions the filter was mashed with 
a mortar and pestle in 20 ml. chilled streptolysin S 
buffer and implanted intraperitoneally in a rabbit. All 
rabbits were bled pre- and post-implantation and were given 
prophylactic antibiotics post-operatively. 
The results of these attempts at immunization are 
presented in figures 13 and 14. After implantation 
streptolysin 3 inhibitor levels rose in rabbits 330, 331 
and 332 (Table X). There was a transient opalescence 
in the post-implantation sera from rabbits 328, 329, 330, 
331 and 332 (Figure 13). 
If one compares SSI levels and opalescence data for 
individual sera as presented in Figure 13, it is evident 
that (1) opalescence occurred in sera from rabbits 328 
and 329 without a concomitant rise in SSI, (2) opalescence 
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occurred in sera from rabbits 331 and 332 with a concomi¬ 
tant rise in SSI and (3) a rise in SSI occurred in serum 
from rabbit 330 without the simultaneous occurrence of 
opalescence. 
Table X 
Rabbit Streptolysin S Inhibitor (units/ml.) Percent 
Pre-implantation Peah VaXue Increase 
Post-imolantation 
330 12.5 33 165% 
331 10 666 6500% 
332 10 33 250% 
On Ouchterlony plates all anti-sera showed no reaction 
with R11A core or RHA-se. Most early post-implantation sera 
reacted with non-dialyzed streptolysin 5 (Pigure 15). One 
pre-implantation serum (rabbit 34-3) and several post¬ 
implantation sera from the control rabbit also reacted with 
the non-dialyzed streptolysin S. Since this precipitation 
reaction occurred so soon after the implantation it could 
not be due to an antibody but could perhaps be due to an 
acute phase reactant. 
There were three rabbits who died on whom a bleeding 
was performed on the day preceding death (rabbits 328, 
329 and 332). The sera from two of these three bleedings 















FIGURE 13- Serum Inhibitor is shown in bar form; opalescence, 0 - 4+, 
and precipitation on Ouchterlony plate of serum against streptolysin S, 
















FIGURE 13- Continued, 
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FIGURE l't- Continued. 
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328 and 329). The significance of this finding is not 
known. 
FIGURE 15—Cuchterlony plate showing the reactivi 
of serum.(post-implantation day 2) from rabbits 3 
and 330, bo.th implanted with streptolysin S bound to 
a Seitz filter: 1. serum, rabbit 328; 2. RRA-se, 
0.1 mgm./ml.; 3. RITA-se, 0.1 mgm./ml.; 4. serum, 
rabbit 330; 5. RITA core, 10 mgm./ml.; 6. R1L4 core, 
10 mgm./ml.; 7. strepoolysin 3, 
The following biochemical changes took place in the 
control rabbit (342) and in a rabbit implanted with strep¬ 






post-operative observation period, which, was limited 
by the survival of the animal, was five weeks for rabbit 
342 and four weeks for rabbit 343. Total lipids, total 
cholesterol, cholesterol esters, and BU1T went up while 
potassium stayed the same after the operative procedure. 
Total lipids returned to the pre-implantation level within 
five weeks for rabbit 342 and two weeks for rabbit 343. 
Total cholesterol returned to the pre-implantation level 
within five weeks for rabbit 342 and did not return to 
‘the pre-implantation level during the observation period 
for rabbit 343. Cholesterol esters and BUN returned to 
the pre-implantation level within three weeks for rabbit 
342 and two weeks for rabbit 343. It is evident from 
Figure 14 that the transient but marked hyperlipemia 
observed post-implantation in one experimental (343) and 
one control animal (342) (the only two animals thus 
studied), occurred primarily in the non-cholesterol portion 
of the serum lipids. 
The antistreptolysin 0 (130) titer was determined 
for all sera in the above experiment. When post-implantation 
sera were compared with pre-implantation sera, no elevation 
in the 130 titer was observed. Therefore, the lipid 
alterations that occurred were not such as to provoke 
inhibition of streptolysin 0 although it is known that 












342 260 750 190^ 
343 120 590 390$ 
Rabbit Total Cholesterol (mgms. %) 




' 342 70 150 115$ 
343 45 115 155$ 
Rabbit Cholesterol Esters (mgms. %) 




342 58 94 62$ 
343 36 85 136$ 







342 12 26 115$ 
343 21 73 250^ 
In the three rabbits which were followed for two 
weeks or more (330, 335 and 343), the absence of an A50 
response argues against a streptococcal infection and 
also argues against the presence of streptolysin 0 in 
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the streptolysin S preparations that were injected, 
bound to a Seitz filter, into each rabbit. 
DISCUSSION 
The present data suggest that streptolysin S when 
injected into rabbits as a complex with MBSA is not anti¬ 
genic. A precipitating antibody was obtained, but gel 
diffusion on Ouchterlony plates demonstrated that it was 
directed against RMi-se. However, conclusions on the lack 
of antigenicity of streptolysin S under these experimental 
conditions must be tempered by the knowledge that the 
immunization efforts were not as vigorous as they might 
have been because of the difficulty of obtaining strepto¬ 
lysin S in large amounts. 
It is quite possible that immunization over a period 
of months might have been successful where our three-week 
schedule (one set of injections per week) failed. The 
formation of antibodies to poorly immunogenic molecules 
can be slow. Satisfactory levels of antibody against 
ACTH were found only after four to five months of 
immunization (14). The immunization of a large number of 




marked individual variations in response to a given 
antigen. Therefore, if one were able to obtain strep¬ 
tolysin S on a commercial basis it would seem worthwhile 
to pursue further the antigenicity of a streptolysin 
S - MESA complex. 
Other problems inherent in the immunisation pro¬ 
cedure may also exist. Although streptolysin S hemo¬ 
lytic activity could be recovered in good yield from 
the precipitate which formed on the addition of MESA 
to streptolysin 3, the streptolysin S - MESA complex 
may deteriorate very shortly after injection into a 
rabbit. This may even occur before the complex has had 
an opportunity to enter and stimulate appropriate anti- 
body-producing cells. Conversely, the streptolysin 3 
may remain buried in the complex, unavailable to the 
antibody forming cells, although it was shown that rabbit 
serum can extract small amounts of it from the complex. 
Moreover, the heat-lability of streptolysin S may render 
it incompetent as an antigenic determinant due to heat 
inactivation after injection even when coupled to a 
carrier such as MESA. 
Another unexplained finding in the current investi¬ 
gation is the lack of an antibody response to methylated 
bovine serum albumin which is known to be antigenic under 
the conditions of the experiment. 
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The results of immunization efforts with RITA are 
somewhat difficult to interpret. Sera from one of the 
six rabbits injected with REA, when placed on an 
Ouchterlony plate, showed a double precipitating system 
against RNA and REA core (with a reaction of identity 
in each of the lines). However, it is interesting that 
pre-injection serum from this same rabbit showed a line 
of precipitation with RITA core. These results would 
suggest the presence of antibodies against two distinct 
constituents of both RITA and RITA core. 
Immunization efforts with RITA core yielded in all 
instances (four rabbits) production of antibodies against 
REA-se. No antibodies against RITA or REA core were 
detected. Perhaps the most likely explanation for the 
lack of an antibody response against RITA and RNA core 
(in all of the above animals except one) is the use of too 
short a period of immunization; further immunization will, 
therefore, be attempted. Another possibility may be an 
inherently lower antigenicity of RNA and RITA core as 
compared to denatured DNA. 
Immunization with streptolysin S coupled by a 
carbodiimide to rabbit serum albumin failed to induce an 
antibody response against streptolysin S. It would seem 
worthwhile to further pursue this approach to immunization 
with streptolysin 3 in the light of the success of 
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Goodfriend _et al. with angiotensin and' bradykinin (23). 
Since the shortcomings of this experiment are similar 
to those discussed for the streptolysin S - MB3A experi¬ 
ment, immunization of a large number of animals over a 
period of months might be helpful. It would also be of 
interest to extract the carbodiimide induced precititate 
in a manner similar to that used in the streptolysin 
S - MB3A studies to ascertain the presence of^strepto- 
lysin 3 in the precipitate and its availability. 
The experiments utilizing a Seitz filter as a 
''carrier” and an "adjuvant” yielded several unexpected 
and interesting results. In the following discussion 
hyperlipemia will indicate a chemically determined 
increase in serum lipids. In five of seven experimental 
animals the serum became opalescent post-implantation 
and in one experimental and one control animal (the only 
two animals thus studied) a transient but marked hyper¬ 
lipemia was observed, characterized by an increase in 
total cholesterol and cholesterol esters. The charac¬ 
teristics of this hyperlipemia may be contrasted to that 
produced by other means. Tsaltas reported that intra¬ 
venous injection of papain produced lipemia in adult 
rabbits (80). Further studies indicated that the 
lipemia was mostly due to a rise in the plasma glyceride 




concentration of the other lipid fractions. The lipemia 
secondary to papain administration was accompanied by 
moderate pulmonary edema and other stress phenomena. 
Tsaltas and button postulated that the stress reaction 
precipitated by the papain injection could be considered 
as the major cause of the lipemia (81). 
It has also been reported that the injection of 
pituitary gland extracts produced a lipemia in rabbits 
which was very similar to the one produced by papain (29). 
Pituitary extracts were found to mobilize free fatty acid 
from adipose tissue. The latter was then resynthesized 
into triglyceride which was directly responsible for a 
lactescent hypertriglyceridemia. 
The lipemia observed in the present study differs 
from those discussed above in degree as well as in compo¬ 
sition. The percent increase in total lipids in the 
papain studies was about 15/5 as compared to a percent 
Increase of 200^5 to 400/5 in the present study. The 
available chemistry determinations show a sharp increase 
in total cholesterol (over 100^5) after the intraper- 
itoneal implantation of the Seitz filter, whether it 
x was impregnated with streptolysin S (experimental rabbit) 
or not (control rabbit). 3y contrast, total cholesterol 
did not change significantly in the papain experiment. 
No data are available on triglycerides' for our experiments. 
* 
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While cholesterol esters rose 60% to 135% in our experi¬ 
ments they fell 25% in the papain experiment. 
In the same phase of the experiment (with respect 
to implantation of the Seitz filter) as was the obser¬ 
vation of a transient hyperlipemia in the two rabbits 
in which it was sought, an increase in streptolysin S 
inhibitor (SSI) varying from 165% to 650O%> was also 
noted in other rabbits (330, 331 and 332). This increase 
in SSI may be related to the marked hyperlipemia dis¬ 
cussed above since previous studies (6l) have demonstrated 
that the SSI activity is associated with a phospholipo- 
protein complex. It should be noted that two of the 
three rabbits showing a significant rise of SSI had been 
implanted with Seitz filters impregnated with a strep¬ 
tolysin 3 preparation which had not been previously 
Millipore-filtered (rabbits 331 and 332). Since it is 
known that such preparations, though clear, contain large 
amounts of living streptococci, it may be inferred that 
these rabbits developed a streptococcal infection. 
Unfortunately, we do not have lipid studies for these 
rabbits. It is pertinent to recall in this connection 
that Todd observed variable increases in 331 (which he 
termed antistreptolysin S) following prolonged courses 
of intravenous injections of living group A streptococci 
into rabbits, ibout half of Todd's rabbits died during 
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the course of the experiment with generalized strep¬ 
tococcal infections (78). 
Another interesting observation in the immunization 
with streptolysin S bound to a Seitz filter was the line 
of precipitation which formed between most early post¬ 
implantation sera and non-dialyzed streptolysin S. This 
precipitation could not be due to an antibody because it 
occurred too soon after the implantation and because it 
even occurred between sera from the control rabbit 
(implanted intraperitoneally with a Seitz filter free of 
streptolysin S) and streptolysin 3. Further studies will 
be performed to elucidate the nature of this reaction. 
SUMMARY 
This thesis investigated the antigenicity of streptolysin S. 
1. Streptolysin 3 when injected into rabbits as a complex 
with MBSA was not antigenic. Precipitating antibodies 
directed against MBSA were not produced. However, a 
precipitating antibody was obtained which was directed 
against RMA-se. (RITA-se was used in the preparation of 




2. Streptolysin S hemolytic activity could be recovered 
in good yield from the precipitate which formed on 
the addition of MBSA to streptolysin S. 
3. Post-injection serum from one of six rabbits injected 
with RITA had antibodies against two distinct constit¬ 
uents of both RNA and RITA core. Pre-injection serum 
from this same rabbit gave a line of precipitation 
with RITA core. 
4. All rabbits injected with RITA core produced antibodies 
against RITA - s e. (RNA-se was used in the preparation of 
RITA core.) No antibodies against RITA core were pro¬ 
duced . 
5. Streptolysin S, coupled by a carbodiimide to rabbit 
serum albumin, was not antigenic when injected into 
a rabbit. 
6. Streptolysin S when passed through a Seitz filter was 
bound to the filter and could be eluted from it by 
solutions of high ionic strength. 
7. Streptolysin 3 when bound to a Seitz filter and implanted 
intraperitoneally in rabbits was not antigenic. In 
some rabbits a marked increase in the streptolysin S 
inhibitor titer was observed post-implantation. In 
one experimental animal and one control animal (the 
only two animals thus studied) a transient but marked 
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